Akzo Nobel Past Earnings Performance
Past criteria checks 4/6
Akzo Nobel's earnings have been declining at an average annual rate of -4.9%, while the Chemicals industry saw earnings declining at 3.8% annually. Revenues have been growing at an average rate of 4.9% per year. Akzo Nobel's return on equity is 12.6%, and it has net margins of 5.3%.
Key information
-4.9%
Earnings growth rate
-0.8%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 4.9% |
| Return on equity | 12.6% |
| Net Margin | 5.3% |
| Next Earnings Update | 29 Jan 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Akzo Nobel makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 10,621 | 565 | 3,048 | 270 |
| 30 Jun 24 | 10,694 | 592 | 3,043 | 270 |
| 31 Mar 24 | 10,651 | 534 | 2,992 | 270 |
| 31 Dec 23 | 10,668 | 447 | 2,962 | 270 |
| 30 Sep 23 | 10,745 | 411 | 2,976 | 258 |
| 30 Jun 23 | 10,866 | 309 | 2,976 | 258 |
| 31 Mar 23 | 10,978 | 303 | 2,983 | 258 |
| 31 Dec 22 | 10,846 | 362 | 2,939 | 258 |
| 30 Sep 22 | 10,643 | 540 | 2,864 | 230 |
| 30 Jun 22 | 10,191 | 616 | 2,766 | 230 |
| 31 Mar 22 | 9,849 | 758 | 2,661 | 230 |
| 31 Dec 21 | 9,587 | 823 | 2,610 | 230 |
| 30 Sep 21 | 9,393 | 805 | 2,618 | 238 |
| 30 Jun 21 | 9,259 | 866 | 2,599 | 238 |
| 31 Mar 21 | 8,735 | 741 | 2,547 | 238 |
| 31 Dec 20 | 8,530 | 637 | 2,579 | 238 |
| 30 Sep 20 | 8,563 | 544 | 2,595 | 262 |
| 30 Jun 20 | 8,685 | 481 | 2,677 | 262 |
| 31 Mar 20 | 9,149 | 567 | 2,764 | 262 |
| 31 Dec 19 | 9,276 | 517 | 2,833 | 262 |
| 30 Sep 19 | 9,342 | 477 | 2,929 | 264 |
| 30 Jun 19 | 9,270 | 463 | 2,918 | 264 |
| 31 Mar 19 | 9,265 | 354 | 3,028 | 264 |
| 31 Dec 18 | 9,256 | 400 | 3,044 | 264 |
| 30 Sep 18 | 9,231 | 393 | 3,005 | 270 |
| 30 Jun 18 | 9,324 | 365 | 3,068 | 270 |
| 31 Mar 18 | 9,411 | 426 | 3,050 | 270 |
| 31 Dec 17 | 9,612 | 439 | 3,107 | 270 |
| 30 Sep 17 | 6,022 | 107 | 2,329 | 257 |
| 30 Jun 17 | 7,203 | 272 | 2,603 | 257 |
| 31 Mar 17 | 8,381 | 417 | 2,888 | 257 |
| 31 Dec 16 | 9,434 | 534 | 3,138 | 257 |
| 30 Sep 16 | 14,300 | 1,032 | 4,158 | 347 |
| 30 Jun 16 | 14,460 | 1,031 | 4,194 | 347 |
| 31 Mar 16 | 14,698 | 1,051 | 4,253 | 347 |
| 31 Dec 15 | 14,859 | 973 | 4,279 | 347 |
| 30 Sep 15 | 14,817 | 772 | 4,295 | 363 |
| 30 Jun 15 | 14,743 | 691 | 4,313 | 363 |
| 31 Mar 15 | 14,504 | 565 | 4,250 | 363 |
| 31 Dec 14 | 14,296 | 528 | 4,203 | 363 |
| 30 Sep 14 | 14,261 | 570 | 4,235 | 373 |
| 30 Jun 14 | 14,353 | 521 | 4,264 | 373 |
| 31 Mar 14 | 14,508 | 623 | 4,343 | 373 |
| 31 Dec 13 | 14,590 | 593 | 4,375 | 373 |
Quality Earnings: 0A00 has high quality earnings.
Growing Profit Margin: 0A00's current net profit margins (5.3%) are higher than last year (3.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0A00's earnings have declined by 4.9% per year over the past 5 years.
Accelerating Growth: 0A00's earnings growth over the past year (37.5%) exceeds its 5-year average (-4.9% per year).
Earnings vs Industry: 0A00 earnings growth over the past year (37.5%) exceeded the Chemicals industry -36.8%.
Return on Equity
High ROE: 0A00's Return on Equity (12.6%) is considered low.